Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Select Medical ( (SEM) ) is now available.
On September 2, 2025, Select Medical Holdings Corporation announced the appointment of Thomas P. Mullin as the new Chief Executive Officer, effective September 1, 2025. This leadership change marks a significant transition as David S. Chernow steps down from the CEO position to become Vice Chairman of the Board. John A. Saich will assume the role of sole President, and John F. Duggan has been named Executive Vice President, General Counsel, and Secretary. These appointments highlight Select Medical’s commitment to its succession planning and growth strategy, aiming to enhance its operations and deliver value to stakeholders.
The most recent analyst rating on (SEM) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Select Medical stock, see the SEM Stock Forecast page.
Spark’s Take on SEM Stock
According to Spark, TipRanks’ AI Analyst, SEM is a Outperform.
Select Medical’s overall score is driven by solid earnings call results and strategic corporate events, countered by technical analysis indicating bearish momentum. Financial performance shows stability, albeit with leverage concerns.
To see Spark’s full report on SEM stock, click here.
More about Select Medical
Select Medical is a leading operator of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. As of June 30, 2025, the company operated 104 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,919 outpatient rehabilitation clinics in 39 states and the District of Columbia.
Average Trading Volume: 1,146,799
Technical Sentiment Signal: Sell
Current Market Cap: $1.61B
Find detailed analytics on SEM stock on TipRanks’ Stock Analysis page.